Approval · Notice of Compliance 32125 · 2023
SOHONOS: Notice of Compliance 32125
Issued November 17, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32125
- Date
- November 17, 2023
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOHONOS | Not yet assigned | — |
Medicinal ingredients
- PALOVAROTENE 1.5 MG per CAP
- PALOVAROTENE 2.5 MG per CAP
- PALOVAROTENE 1 MG per CAP
- PALOVAROTENE 5 MG per CAP
- PALOVAROTENE 10 MG per CAP